Anti-Interferon Alpha2

• Description:

  Anti-Interferon Alpha2_x000D_ Catalog number: B2015745_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20 °C_x000D_ Keywords: Anti-Interferon Alpha2_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Qi Y, Zhang LJ, Zhang QX, Wang J, Yang L. [Clinical significance of anti-interferon -α2 and anti-interferon -ω antibody in myasthenia gravis] Zhonghua Yi Xue Za Zhi. 2019 Nov 5;99(41):3227-3231._x000D_ 2: Stancek D, Fuchsberger N, Oltman M, Schmeisser H, Kontsek P, Jahnová E, Hajnická V. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virol. 2001;45(5-6):287-92._x000D_ 3: Bodansky A, Vazquez SE, Chou J, Novak T, Al-Musa A, Young C, Newhams M, Kucukak S, Zambrano LD, Mitchell A, Wang CY, Moffitt K, Halasa NB, Loftis LL, Schwartz SP, Walker TC, Mack EH, Fitzgerald JC, Gertz SJ, Rowan CM, Irby K, Sanders RC Jr, Kong M, Schuster JE, Staat MA, Zinter MS, Cvijanovich NZ, Tarquinio KM, Coates BM, Flori HR, Dahmer MK, Crandall H, Cullimore ML, Levy ER, Chatani B, Nofziger R; Overcoming COVID-19 Network Study Group Investigators,; Geha RS, DeRisi J, Campbell AP, Anderson M, Randolph AG. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications J Allergy Clin Immunol. 2023 Apr;151(4):926-930.e2._x000D_ 4: Maurer B, Bosanac I, Shia S, Kwong M, Corpuz R, Vandlen R, Schmidt K, Eigenbrot C. Structural basis of the broadly neutralizing anti-interferon-α antibody rontalizumab Protein Sci. 2015 Sep;24(9):1440-50._x000D_ 5: Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1 PLoS Med. 2006 Jul;3(7):e289._x000D_ 6: Chen SH, Chen SS, Wang YP, Chen LK. Effects of systemic and neuraxial morphine on the immune system Medicine (Baltimore). 2019 May;98(19):e15375._x000D_ 7: Bonetti P, Diodati G, Drago C, Casarin C, Scaccabarozzi S, Realdi G, Ruol A, Alberti A. Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha J Hepatol. 1994 Mar;20(3):416-20._x000D_ 8: Cufi P, Soussan P, Truffault F, Fetouchi R, Robinet M, Fadel E, Berrih-Aknin S, Le Panse R. Thymoma-associated myasthenia gravis: On the search for a pathogen signature J Autoimmun. 2014 Aug;52:29-35._x000D_ 9: Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Bøe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager A. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I J Clin Endocrinol Metab. 2008 Nov;93(11):4389-97._x000D_ 10: Ushio C, Ariyasu H, Kayano T, Ohta H, Aga M, Ariyasu T, Ohta T, Kurimoto M, Fukuda S. Establishment of antihuman IFN-alpha8-specific monoclonal antibodies and their application in the enzyme-linked immunosorbent assay (ELISA) J Interferon Cytokine Res. 2008 Jun;28(6):359-66. _x000D_ _x000D_ Products Related to Anti-Interferon Alpha2 can be found at Antibodies

• Short Description:

  Catalog Number: B2015745 (50 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4